Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Matthews

Showing results (51-60 of 115) with videos related to

Pageof 12
Sort By:
Diabetes Technology & Therapeutics|July 1, 2011
Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groupsNathan R Hill, Nick S Oliver, Pratik Choudhary, et al.
Public Health Nursing (Boston, Mass.)|March 25, 2015
Reducing Health Risk Factors in Workplaces of Low and Middle-Income CountriesDenis Anthony, Pamela A Dyson, Jun Lv, et al.
Diabetes, Obesity & Metabolism|September 21, 2021
Sotagliflozin for patients with type 2 diabetes: A systematic review and meta-analysisIoannis Avgerinos, Thomas Karagiannis, Panagiota Kakotrichi, et al.
Diabetes, Obesity & Metabolism|July 31, 2018
Glucagon-like peptide-1 receptor agonists and microvascular outcomes in type 2 diabetes: A systematic review and meta-analysisIoannis Avgerinos, Thomas Karagiannis, Konstantinos Malandris, et al.
Expert Opinion on Pharmacotherapy|April 28, 2017
Once-weekly dipeptidyl peptidase-4 inhibitors for type 2 diabetes: a systematic review and meta-analysisDimitrios Stoimenis, Thomas Karagiannis, Anastasia Katsoula, et al.
Diabetes Care|January 14, 2010
Changes in prandial glucagon levels after a 2-year treatment with vildagliptin or glimepiride in patients with type 2 diabetes inadequately controlled with metformin monotherapyBo Ahrén, James E Foley, Ele Ferrannini, et al.
Diabetes, Obesity & Metabolism|September 7, 2020
Early combination therapy delayed treatment escalation in newly diagnosed young-onset type 2 diabetes: A subanalysis of the VERIFY studyJuliana C N Chan, Päivi M Paldánius, Chantal Mathieu, et al.
The Journal of Clinical Endocrinology and Metabolism|May 8, 2002
Oral hydrocortisone administration in children with classic 21-hydroxylase deficiency leads to more synchronous joint GH and cortisol secretionEvangelia Charmandari, Steven M Pincus, David R Matthews, et al.
Asia-Pacific Journal of Public Health|March 20, 2012
Tobacco smoking among school children in Colombo district, Sri LankaPrasad Katulanda, Isurujith Kongala Liyanage, Kremlin Wickramasinghe, et al.
Diabetes Care|December 25, 2003
Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66Richard J Stevens, Ruth L Coleman, Amanda I Adler, et al.
Pageof 12

Showing results (51-60 of 115) with videos related to

Sort By:
Pageof 12
Diabetes Technology & Therapeutics|July 1, 2011
Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groupsNathan R Hill, Nick S Oliver, Pratik Choudhary, et al.
Public Health Nursing (Boston, Mass.)|March 25, 2015
Reducing Health Risk Factors in Workplaces of Low and Middle-Income CountriesDenis Anthony, Pamela A Dyson, Jun Lv, et al.
Diabetes, Obesity & Metabolism|September 21, 2021
Sotagliflozin for patients with type 2 diabetes: A systematic review and meta-analysisIoannis Avgerinos, Thomas Karagiannis, Panagiota Kakotrichi, et al.
Diabetes, Obesity & Metabolism|July 31, 2018
Glucagon-like peptide-1 receptor agonists and microvascular outcomes in type 2 diabetes: A systematic review and meta-analysisIoannis Avgerinos, Thomas Karagiannis, Konstantinos Malandris, et al.
Expert Opinion on Pharmacotherapy|April 28, 2017
Once-weekly dipeptidyl peptidase-4 inhibitors for type 2 diabetes: a systematic review and meta-analysisDimitrios Stoimenis, Thomas Karagiannis, Anastasia Katsoula, et al.
Diabetes Care|January 14, 2010
Changes in prandial glucagon levels after a 2-year treatment with vildagliptin or glimepiride in patients with type 2 diabetes inadequately controlled with metformin monotherapyBo Ahrén, James E Foley, Ele Ferrannini, et al.
Diabetes, Obesity & Metabolism|September 7, 2020
Early combination therapy delayed treatment escalation in newly diagnosed young-onset type 2 diabetes: A subanalysis of the VERIFY studyJuliana C N Chan, Päivi M Paldánius, Chantal Mathieu, et al.
The Journal of Clinical Endocrinology and Metabolism|May 8, 2002
Oral hydrocortisone administration in children with classic 21-hydroxylase deficiency leads to more synchronous joint GH and cortisol secretionEvangelia Charmandari, Steven M Pincus, David R Matthews, et al.
Asia-Pacific Journal of Public Health|March 20, 2012
Tobacco smoking among school children in Colombo district, Sri LankaPrasad Katulanda, Isurujith Kongala Liyanage, Kremlin Wickramasinghe, et al.
Diabetes Care|December 25, 2003
Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66Richard J Stevens, Ruth L Coleman, Amanda I Adler, et al.
Pageof 12